Generation Bio Current Ratio 2020-2023 | GBIO
Generation Bio current ratio from 2020 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Generation Bio Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2023-12-31 |
$0.27B |
$0.04B |
6.83 |
| 2023-09-30 |
$0.30B |
$0.03B |
9.07 |
| 2023-06-30 |
$0.32B |
$0.03B |
12.11 |
| 2023-03-31 |
$0.35B |
$0.02B |
15.16 |
| 2022-12-31 |
$0.29B |
$0.02B |
14.99 |
| 2022-09-30 |
$0.31B |
$0.02B |
17.93 |
| 2022-06-30 |
$0.32B |
$0.02B |
19.84 |
| 2022-03-31 |
$0.34B |
$0.02B |
22.39 |
| 2021-12-31 |
$0.38B |
$0.02B |
20.16 |
| 2021-09-30 |
$0.40B |
$0.02B |
27.80 |
| 2021-06-30 |
$0.43B |
$0.01B |
31.06 |
| 2021-03-31 |
$0.46B |
$0.01B |
42.23 |
| 2020-12-31 |
$0.27B |
$0.01B |
23.86 |
| 2020-09-30 |
$0.29B |
$0.01B |
31.19 |
| 2020-06-30 |
$0.31B |
$0.01B |
26.54 |
| 2020-03-31 |
$0.00B |
|
0.00 |
| 2019-12-31 |
$0.00B |
|
0.00 |
| 2019-09-30 |
$0.00B |
|
0.00 |
| 2019-06-30 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$0.193B |
$0.006B |
|
Generation Bio Co. is a genetic medicines company. It is focused on creating gene therapy for patients suffering from both rare and prevalent diseases. Generation Bio Co. is based in CAMBRIDGE, Mass.
|
